As part of the agreement, Sanofi will provide Alloy with upfront license fees and near-term preclinical milestone payments up ...
Maravai LifeSciences Holdings said Wednesday it expects to report full-year revenue for 2024 near the midpoint of its most recent outlook. The San Diego company has guided for full-year revenue ...
Increases speed to market for drug developers working on nucleic acid therapeutics.
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to ...
The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...
After years of restructuring, Chicago-based Exicure has South Korean majority ownership and is buying the U.S. arm of a South ...
Adenosine deaminase 2 (ADA2) has been identified as a regulator of toll-like receptor 9 (TLR9) activation in response to nucleic acids, according to a recent study.
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.TRc4SPmX.js ...
A case study published by researchers at Johns Hopkins University showed that optical genome mapping (OGM) detected a structural variant that was ...